From Health Affairs Today <[email protected]>
Subject Targeted Coronavirus Testing Is Essential For Health Equity; The VA-ICER Pharmaceutical Assessment Collaboration; Treatment Of Opioid Use Disorder
Date June 15, 2020 8:05 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
 

View Message in Browser

[link removed]

 

[link removed]

 

[link removed]

 

[link removed]

 

mailto:[email protected]

[link removed]

**The Latest Research, Commentary, and News from Health Affairs**

**Monday, June 15, 2020**

TODAY ON THE BLOG
COVID-19

Targeted Coronavirus Testing Is Essential For Health Equity

By Ryan Huerto, Susan Goold, and Duane Newton

Minoritized and low-income populations are at greater risk of COVID-19
infection and mortality. Prioritizing testing in these and other
marginalized communities could enable those at higher risk for severe
illness and, typically, worse access to care, to be more safely
monitored and promptly treated.Read More >>

CONSIDERING HEALTH SPENDING

VA And ICER At Three Years: Critics' Concerns Answered

By Peter A. Glassman, Steven D. Pearson, Jennifer Zacher, David Rind,
and Michael A. Valentino

In June 2017 the Department of Veterans Affairs (VA) entered a
relationship with the Institute for Clinical and Economic Review in
order to enhance the VA's internal evidence review processes. Given the
initial concerns that were raised when this collaboration was first
announced, we provide an update on the successes and challenges of this
partnership. Read More >>

This post appears in the series Considering Health Spending.

[link removed]

IN THE JOURNAL

OPIOID USE DISORDER

Buprenorphine Treatment By Primary Care Providers, Psychiatrists,
Addiction Specialists, And Others

By Mark Olfson, Victoria Zhang, Michael Schoenbaum, and Marissa King

Using a national prescription database that covered 72-92 percent of
the US population during 2010-18, Mark Olfson and coauthors analyzed
trends in buprenorphine treatment by prescriber specialty. Read More >>

Treatment Of Opioid Use Disorder Among Commercially Insured US Adults,
2008-17

By Karen Shen, Eric Barrette, and Leemore S. Dafny

There is abundant literature on efforts to reduce opioid prescriptions
and misuse, but comparatively little on the treatment provided to people
with opioid use disorder (OUD). Using claims data representing 12-15
million nonelderly adults covered through commercial group insurance
during the period 2008-17, Karen Shen and coauthors explored rates of
OUD diagnoses, treatment patterns, and spending. Read More >>

Read the June 2020 Table of Contents
.

Subscribe to Health Affairs for full journal access.

**A CLOSER LOOK**-Mental Health Care

Members of racial and ethnic minority groups with mental illness are
rarely included in prioritizing research topics or developing the tools
and measures important for improving their care. In their March 2019
research article, Jonathan Delman and coauthors explore the possibility
that community-based participatory research could help to reduce these
disparities
, noting
that there are challenges in engaging community stakeholders.

[link removed]

[link removed]

 

[link removed]

 

[link removed]

 

[link removed]

About Health Affairs

Health Affairs is the leading peer-reviewed journal
at the intersection of health,
health care, and policy. Published monthly by Project HOPE, the journal
is available in print and online. Late-breaking content is also found
through healthaffairs.org , Health Affairs
Today , and Health Affairs
Sunday Update .  

Project HOPE is a global health and
humanitarian relief organization that places power in the hands of local
health care workers to save lives across the globe. Project HOPE has
published Health Affairs since 1981.

Copyright © Project HOPE: The People-to-People Health Foundation, Inc.

Health Affairs, 7500 Old Georgetown Road, Suite 600, Bethesda, MD 20814, United States

Privacy Policy

To unsubscribe from this email, click here
.                 
                                               
                        I
Screenshot of the email generated on import

Message Analysis